Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-01-03 @ 8:45 AM
Study NCT ID:
NCT01699061
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2012-10-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Tivantinib on the QTC Interval in Cancer Subjects
Sponsor:
Daiichi Sankyo
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ARQ197-A-U159
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |